Atricure Inc. buy Needham & Company LLC
Start price
29.11.23
/
50%
€34.00
Target price
29.11.24
€44.64
Performance (%)
-
End price
30.11.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | -5.028% | -5.028% | -45.161% |
| iShares Core DAX® | 0.374% | 4.635% | 21.570% |
| iShares Nasdaq 100 | 1.487% | 2.950% | 6.389% |
| iShares Nikkei 225® | -0.725% | 0.403% | 14.348% |
| iShares S&P 500 | 0.822% | 2.058% | 3.773% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $49.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten